Novavax (NVAX) Tops Q3 EPS by 1c

Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $6.42 million.

For earnings history and earnings-related data on Novavax (NVAX) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• Franklin Covey (FC) Misses Q3 EPS by 2c, lowers Guidance
• General Mills (GIS) Tops Q4 EPS by 14c, Beats on Revenue; Offers FY27 EPS Guidance